Please enable Javascript
Kevin M. Alexander, MD
Kevin M. Alexander, MD
Kevin M. Alexander, MD
Articles by Kevin M. Alexander, MD
How to Expedite ATTR-CM Treatment in a Clinical Setting
CardioNerds
AHA 2024: CardioNerds
|
February 5, 2025
Dr. Kevin Alexander speaks with The CardioNerds about the importance of providing swift treatment to patients with ATTR-CM.
View More
Acoramidis Therapy Yields Positive Results in Patients With ATTR-CM by Reducing Hospitalizations
CardioNerds
AHA 2024: CardioNerds
|
February 5, 2025
The CardioNerds, Dr. Alexander discuss how acoramidis therapy works, and details data Dr. Alexander presented at AHA 2024.
View More
A Detailed Overview of ATTR Cardiomyopathy
Kevin M. Alexander, MD
AHA 2024: CardioNerds
|
January 30, 2025
Dr. Georgia Vasilakis Tsatiris of The CardioNerds speaks to Dr. Kevin Alexander about the impact of ATTR-CM.
View More
Acoramidis Treatment Is Effective in Patients With ATTR-CM
CardioNerds
CardioNerds
|
April 17, 2025
The CardioNerds and Dr. Alexander discuss the findings of the ATTRibute-CM clinical trial.
View More
How Biomarkers Like NT-proβNP-1 Help Define Progression in ATTR-CM
CardioNerds
CardioNerds
|
April 17, 2025
The CardioNerds and Dr. Alexander analyze biomarkers in ATTR-CM.
View More
The CardioNerds and Dr. Kevin Alexander Discuss ATTR-CM, Transthyretin Instability
CardioNerds
CardioNerds
|
April 17, 2025
The CardioNerds and Dr. Kevin M. Alexander discuss the nuances of transthyretin amyloid cardiomyopathy.
View More